{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"30"}]}]}],"denomUnitsSelected":"Number of Surgeries","denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"37"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"38"}],"units":"Number of Surgeries"}],"description":"Of the 43 participants enrolled on this trial, 37 met criteria for evaluation of neuropathic pain (NP) following definitive surgery. The 37 participants underwent 38 surgeries: one participant had a limb-sparing surgery followed by an amputation surgery. Six of 43 participants were excluded from evaluation for NP: 1 due to deep vein thrombosis, 2 removed from study prior to surgery, 1 removed immediately after surgery to receive radiation therapy, 1 had non-extremity osteosarcoma, and 1 patient had a fibula resection. Patients were followed for neuropathic pain daily for the first week postoperatively and weekly for up to 6 months postoperatively.","groups":[{"description":"Participants had metastatic disease at diagnosis.","id":"OG000","title":"Amputation Group"},{"description":"Participants had localized disease at diagnosis. One participant had 2 surgeries.","id":"OG001","title":"Limb Sparing Group"},{"description":"Participants enrolled on the study who met the criteria for evaluation of neuropathic pain.","id":"OG002","title":"Entire Study Group"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 6 months postoperatively","title":"Number of Participants With Neuropathic Pain (NP) Following Surgery","type":"OTHER_PRE_SPECIFIED","typeUnitsAnalyzed":"Number of Surgeries","unitOfMeasure":"participants"}